Antibiotic-resistant bacteria were responsible for nearly 5 million deaths globally in 2019, as detailed in The Lancet. The rise and fall of antibiotics is a topic that is deeply personal to Dr. Ana Santos, who led the EU-funded project REBELLION.
Nanoparticles co-assembled by Fmoc-protected tyrosine and tryptophan were crosslinked by ultraviolet light irradiation in a new study from JAIST researchers in the hopes of offering a new approach to controlled anticancer therapy.
Lung cancer diagnosis could soon be as simple as breathing nanoparticle sensors and then undergoing a urine test to determine whether a tumor is present, thanks to new technology developed at MIT.
The Hong Kong University of Science and Technology (HKUST)-led research team has created an optical plasmonic tweezer-controlled Surface-Enhanced Raman Spectroscopy (SERS) platform that allows for the on-and-off control of light to probe different amylin species in mixtures at the single-molecule level.
A recent study shows a key mechanism by which anti-CTLA-4 antibodies create inflammatory toxicities during anticancer immune checkpoint inhibitor therapies: microbiota-reactive T cells cause colitis in mice harboring the microbiota of wild-caught mice after CTLA-4 blockade.
A nanostructure enhancing tumor detection and treatment has been innovatively developed by a research team led by Prof. Zhengyan Wu at the Hefei Institutes of Physical Science.
Pablo S. Valera, a pre-PhD researcher, completed a study just published in PNAS. The study highlights the potential of Surface-Enhanced Raman spectroscopy (SERS) in investigating metabolites released by cancer cells.
Patients who suffer from certain long-term diseases might have to wait years to receive an accurate diagnosis. For instance, numerous pulmonary and cardiovascular problems can present with symptoms similar to shortness of breath.
The Chinese Academy of Sciences’ Institute of Process Engineering (IPE) researchers have developed a novel vaccination delivery strategy called “nano-micro composite.” Using nano-micro composite multilevel structures, they have created a single-dose, dry powder, inhalable vaccine platform based on this concept.
Researchers at Johns Hopkins have discovered small particles that enhance therapeutic cancer vaccinations, which train the immune system to fight cancerous growths.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.